A requirement for a topical skin protectant (TSP) to protect skin from toxic chemical warfare (CW) agents was recognized immediately following the introduction of these agents in World War I. As early as the summer of 1917, research activities of the US Army were at work examining various soaps and
Development of a reactive topical skin protectant
β Scribed by Ernest H. Braue Jr
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 577 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0260-437X
No coin nor oath required. For personal study only.
β¦ Synopsis
The use of a topical skin protectant (TSP) as a means of protecting troops from percutaneous chemical warfare agent (CWA) exposure has been proposed since these weapons were first used during World War I. The TSP is applied to vulnerable skin surfaces prior to entry into a chemical combat area. In 1990, the US Army Medical Research Institute of Chemical Defense transferred two non-reactive TSPs into advanced development. Following US Food and Drug Administration approval, the final product is expected to be available to soldiers in 1999. A continuing research effort is designed to develop a second-generation TSP that will increase effectiveness and also decontaminate CWAs into non-toxic products. We identified a list of 29 reactive moieties as potential additives to the TSP formulation. All candidate formulations are evaluated in a decision tree network, consisting of a series of 11 efficacy testing models. A prototype formulation (ICD 2701) containing the reactive ingredient S-330 has dramatically improved the protection against saturated sulfur mustard vapor. In addition, we have discovered a compound (ICD 2837) that significantly increases the skin's natural resistance to CWA penetration. Our goal is to transfer a significantly improved TSP formulation into advanced development by 1999.
π SIMILAR VOLUMES
A topical skin protectant (TSP) (ICD 2289) is being developed to protect service members from exposure to chemical warfare agents (CWA). The TSP is designed for use on the skin at the overgarment closures and other vulnerable areas to enhance protection. The TSP, which is in phase II clinical studie
The potential for highly reactive nanoparticles (RNP) to absorb destructively, i.e. to neutralize highly toxic substances such as the warfare agents GA, GB, HD and VX, has been demonstrated in the laboratory. Reactive nanoparticles represent a new class of nanoscale particles of metals and metal oxi
Sulfur mustard (HD; 2,2Π-dichlorodiethyl sulfide) can produce incapacitating blisters in humans following dermal exposure. Most non-human animal models, however, do not form the large fluid-filled blisters observed in humans. Many models, nevertheless, do produce similar damage at the dermal/epiderm
Epigallocatechin gallate (EGCG) is a potent polyphenolic antioxidant extracted from green tea. Due to its antimutagenic and antitumor activities, it is a promising candidate for use in topical formulations for skin cancer prevention. The overall goal of this study was therefore to determine the inΒ―u